US FDA extends review of Wyeth's Prevnar-13 by three months
This article was originally published in Scrip
Executive Summary
The US FDA has postponed the PDUFA date of Wyeth's 13-valent pneumococcal vaccine, Prevnar-13, by three months to December the 30th.